HUMNYSEHospital & Medical Service PlansFiscal year ends December 31
HUMANA INC
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 29, 2026
$414.98+1.82 (+0.44%)
Close on Oct 19, 2026
- Market cap
- $50.07B
- P/E (TTM)
- 44.2
- Dividend yield
- 0.85%
Humana statistics
Financials through Mar 31, 2026, price as of Oct 19, 2026, median of Hospital & Medical Service Plans companies for comparison
Valuation
| Measure | Humana | Industry median |
|---|---|---|
| Market Cap | $49.83B | $3.25B |
| Enterprise Value | $41.92B | $2.52B |
| PE Ratio | 44.24 | 10.38 |
| PS Ratio | 0.36 | 1.08 |
| PB Ratio | 2.68 | 1.48 |
| P/TBV Ratio | 7.22 | 1.56 |
| P/FCF Ratio | 39.18 | 7.95 |
| P/OCF Ratio | 27.02 | 7.31 |
Enterprise value
| Measure | Humana | Industry median |
|---|---|---|
| EV / Sales | 0.31 | 0.93 |
| EV / EBITDA | 13.43 | 6.38 |
| EV / EBIT | 17.15 | 8.98 |
| EV / FCF | 32.96 | 7.33 |
Income (trailing twelve months)
| Measure | Humana | Industry median |
|---|---|---|
| Revenue | $137.20B | $4.57B |
| Operating Income | $2.44B | $617.20M |
| Pretax Income | $1.34B | $589.53M |
| Net Income | $1.13B | $470.80M |
| EBITDA | $3.12B | $657.96M |
| EPS (Diluted) | $9.38 | $4.71 |
Margins
| Measure | Humana | Industry median |
|---|---|---|
| Operating Margin | 1.78% | 4.46% |
| Pretax Margin | 0.98% | 13.7% |
| Profit Margin | 0.82% | 10.7% |
| EBITDA Margin | 2.28% | 13.5% |
| FCF Margin | 0.93% | 17.5% |
Returns
| Measure | Humana | Industry median |
|---|---|---|
| Return on Equity (ROE) | 6.22% | 13.9% |
| Return on Assets (ROA) | 2.13% | 3.31% |
| Return on Invested Capital (ROIC) | 20.6% | 19.7% |
| Return on Capital Employed (ROCE) | 7.24% | 6.00% |
Growth
| Measure | Humana | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 14.1% | 8.06% |
| Net Income Growth (YoY) | -33.9% | 25.1% |
| EPS Growth (YoY) | -33.8% | 27.7% |
| FCF Growth (YoY) | -46.6% | 7.71% |
| Revenue Growth (3Y CAGR) | 11.8% | 9.53% |
| Revenue Growth (5Y CAGR) | 10.9% | 8.29% |
| EPS Growth (3Y CAGR) | -23.6% | 15.9% |
| EPS Growth (5Y CAGR) | -17.2% | 15.2% |
Balance sheet
| Measure | Humana | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $21.97B | $482.49M |
| Total Debt | $13.99B | $859.00M |
| Net Cash (Debt) | $7.97B | $300.85M |
| Net Cash Per Share | $66.39 | $5.27 |
| Equity (Book Value) | $18.58B | $3.63B |
| Book Value Per Share | $154.73 | $41.34 |
| Tangible Book Value | $6.90B | $2.59B |
| Working Capital | $16.57B | $313.96M |
Financial position
| Measure | Humana | Industry median |
|---|---|---|
| Current Ratio | 1.77 | 1.45 |
| Quick Ratio | 1.26 | 0.98 |
| Debt / Equity | 0.75 | 0.27 |
| Debt / EBITDA | 4.48 | 2.36 |
| Debt / FCF | 11.00 | 2.10 |
| Net Debt / EBITDA | -2.55 | -0.40 |
| Interest Coverage | 3.68 | 4.13 |
Cash flow (trailing twelve months)
| Measure | Humana | Industry median |
|---|---|---|
| Operating Cash Flow | $1.84B | $631.50M |
| Capital Expenditures | -$572.00M | -$11.90M |
| Free Cash Flow | $1.27B | $661.55M |
| FCF Per Share | $10.59 | $8.91 |
Efficiency
| Measure | Humana | Industry median |
|---|---|---|
| Asset Turnover | 2.58 | 0.27 |
| Revenue Per Employee | $2.05M | $1.68M |
| Profits Per Employee | $16.85K | $188.96K |
| Employee Count | 67,060 | 1,400 |
Dividends and yields
| Measure | Humana | Industry median |
|---|---|---|
| Earnings Yield | 2.27% | 9.43% |
| FCF Yield | 2.55% | 12.5% |
| Dividend Yield | 0.85% | 2.02% |
| Buyback Yield | 0.50% | 2.87% |
| Shareholder Yield | 1.35% | 4.57% |
| Dividend Per Share | $3.54 | $1.75 |
| Dividend Growth (YoY) | 0.00% | 4.86% |
| Years of Dividend Growth | 0 | 3 |
| Payout Ratio | 38.0% | 20.2% |
| FCF Payout Ratio | 33.7% | 16.0% |
Shares
| Measure | Humana | Industry median |
|---|---|---|
| Shares Outstanding | 120,080,000 | 65,596,200 |
| Shares Change (YoY) | 0.01% | -1.19% |
| Float | 119,684,000 | 56,719,400 |
| Shares Held by Insiders | 0.33% | 3.34% |
| Shares Held by Institutions | 98.6% | 85.3% |
Taxes
| Measure | Humana | Industry median |
|---|---|---|
| Income Tax | $239.00M | $105.00M |
| Effective Tax Rate | 17.8% | 19.8% |
Scores
| Measure | Humana | Industry median |
|---|---|---|
| Graham Number | $180.71 | $76.86 |
| Graham Upside | -56.5% | 18.9% |
| Altman Z-Score | 4.57 | 0.87 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Humana's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.